Wespac Advisors, LLC Abbott Laboratories Transaction History

Wespac Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 03, 2021	SELL	$105.79 - $124.53 $1.17 Million - $1.38 Million	-11,087 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$108.84 - $128.23 $223,230 - $262,999	-2,051 Reduced 15.61%	11,087 $1.33 Million
Q4 2020 Feb 02, 2021	BUY	$105.0 - $114.42 $245,910 - $267,971	2,342 Added 21.69%	13,138 $1.44 Million
Q3 2020 Oct 27, 2020	SELL	$91.64 - $111.29 $666,314 - $809,189	-7,271 Reduced 40.24%	10,796 $1.18 Million
Q2 2020 Jul 22, 2020	SELL	$76.57 - $98.0 $75,191 - $96,236	-982 Reduced 5.16%	18,067 $1.65 Million
Q1 2020 Apr 22, 2020	SELL	$62.82 - $91.86 $125,891 - $184,087	-2,004 Reduced 9.52%	19,049 $1.5 Million
Q4 2019 Feb 07, 2020	SELL	$78.51 - $87.4 $9,421 - $10,488	-120 Reduced 0.57%	21,053 $1.83 Million
Q3 2019 Oct 29, 2019	SELL	$81.84 - $88.74 $609,053 - $660,403	-7,442 Reduced 26.01%	21,173 $1.77 Million
Q2 2019 Jul 23, 2019	BUY	$72.88 - $85.0 $2.09 Million - $2.43 Million	28,615 New	28,615 $2.41 Million

3,136

1.33B

8.63M

7.17M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Wespac Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Wespac Advisors, LLC with notifications on news.